| S1481 |
Zosuquidar 3HCl
|
Zosuquidar 3HCl is a potent modulator of P-glycoprotein-mediated multi-drug resistance with Ki of 60 nM in a cell-free assay. Phase 3.
|
-
bioRxiv, 2025, 2025.06.18.660465
-
Hepatol Commun, 2024, 8(5)e0437
-
Adv Healthc Mater, 2022, e2201984
|
|
| E1781 |
Biricodar
|
Biricodar(VX-710) is a modulator of P-glycoprotein and MRP-1 with minimal in vivo toxicity. It enhances the effectiveness of various antibiotics against numerous gram-positive pathogens and exhibits potent chemosensitizing properties in cells resistant to multiple drugs.
|
|
|
| S9201 |
Levistilide A
|
Levistilide A (Diligustilide), a natural compound isolated from the traditional Chinese herb Ligusticum chuanxiong Hort, is a potential P-gp modulator and used for treating cancer.
|
|
|
| S4662 |
Atazanavir
|
Atazanavir (Latazanavir, Zrivada, Reyataz, BMS-232632) is an azapeptide and HIV-protease inhibitor that is used in the treatment of HIV infections and AIDS in combination with other anti-HIV agents. This compound is a substrate and inhibitor of cytochrome P450 isozyme 3A (CYP3A4) and an inhibitor and inducer of P-glycoprotein.
|
-
Int J Mol Sci, 2022, 23(23)15380
-
Chemistry, 2022, e202202798.
-
Cells, 2021, 10(12)3458
|
|